US Stock MarketDetailed Quotes
MTNB Matinas BioPharma
- 0.5674
- -0.0145-2.49%
Close Nov 4 16:00 ET
- 0.5314
- -0.0360-6.34%
Post 18:36 ET
2.85MMarket Cap-103P/E (TTM)
0.5800High0.5052Low269.17KVolume0.5600Open0.5819Pre Close146.89KTurnover5.51%Turnover RatioLossP/E (Static)5.02MShares21.500052wk High0.15P/B2.77MFloat Cap0.505252wk Low--Dividend TTM4.89MShs Float197.5000Historical High--Div YieldTTM12.85%Amplitude0.5052Historical Low0.5450Avg Price1Lot Size
Matinas BioPharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -41.63%-3.11M | -41.15%-5.77M | 20.24%-15.28M | -6.51%-4.58M | 11.09%-4.42M | 57.26%-2.19M | 14.07%-4.09M | -25.84%-19.16M | -8.64%-4.3M | 13.56%-4.97M |
| Net income from continuing operations | 5.63%-5.72M | -5.64%-5.82M | -9.26%-22.94M | -46.23%-5.31M | -10.86%-6.06M | -2.31%-6.06M | 7.78%-5.51M | 9.82%-21M | 45.75%-3.63M | 20.11%-5.46M |
| Operating gains losses | ---- | ---- | -50.00%1K | ---- | ---- | ---- | ---- | 0.00%2K | ---- | ---- |
| Depreciation and amortization | 2.99%241K | 4.80%240K | 4.79%941K | 6.19%240K | 3.48%238K | 1.30%234K | 8.53%229K | 14.98%898K | 10.45%226K | 17.32%230K |
| Other non cash items | -227.59%-37K | -59.09%18K | -78.69%107K | -67.92%17K | -64.58%17K | -40.82%29K | -87.50%44K | -65.38%502K | -31.85%53K | -96.20%48K |
| Change In working capital | -40.82%1.42M | -906.72%-1.2M | 134.81%1.67M | 65.22%-795K | 115.43%185K | 440.83%2.4M | 80.20%-119K | -411.99%-4.79M | -265.31%-2.29M | 16.37%-1.2M |
| -Change in prepaid assets | -35.18%1.21M | -116.24%-393K | 194.90%3.98M | 99.15%-13K | 54.31%-286K | 185.73%1.86M | 1,883.61%2.42M | -410.89%-4.2M | -219.51%-1.52M | 62.32%-626K |
| -Change in payables and accrued expense | -44.76%369K | 72.95%-651K | -2,336.11%-1.75M | 0.79%-631K | 240.64%616K | -58.20%668K | -303.86%-2.41M | -111.16%-72K | -371.37%-636K | -227.81%-438K |
| -Change in other current liabilities | -17.91%-158K | -16.67%-154K | -8.08%-562K | -17.05%-151K | -7.41%-145K | -3.88%-134K | -3.94%-132K | -13.04%-520K | -3.89%-129K | -17.38%-135K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -41.63%-3.11M | -41.15%-5.77M | 20.24%-15.28M | -6.51%-4.58M | 11.09%-4.42M | 57.26%-2.19M | 14.07%-4.09M | -25.84%-19.16M | -8.64%-4.3M | 13.56%-4.97M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -147.40%-2.94M | -33.33%2M | 171.52%13.24M | 7,147.62%2.96M | -81.15%1.08M | 263.45%6.2M | 1.32%3M | -70.92%4.88M | -174.14%-42K | 2,269.23%5.75M |
| Net PPE purchase and sale | ---- | ---- | 75.56%-218K | --0 | 93.60%-16K | ---- | ---- | -243.08%-892K | -17.28%-42K | -11.51%-250K |
| Net investment purchase and sale | -145.91%-2.94M | -33.33%2M | 133.32%13.46M | --2.96M | -81.67%1.1M | 271.26%6.4M | -14.43%3M | -66.12%5.77M | --0 | 1,185.12%6M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -147.40%-2.94M | -33.33%2M | 171.52%13.24M | 7,147.62%2.96M | -81.15%1.08M | 263.45%6.2M | 1.32%3M | -70.92%4.88M | -174.14%-42K | 2,269.23%5.75M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 919,000.00%9.19M | 1,425.00%53K | -108.86%-7K | 80.00%-1K | 66.67%-1K | 83.33%-1K | -104.30%-4K | -98.87%79K | -160.02%-5K | 63.96%-3K |
| Net issuance payments of debt | 0.00%-1K | 75.00%-1K | 65.00%-7K | 80.00%-1K | 66.67%-1K | 83.33%-1K | 33.33%-4K | 33.33%-20K | 9.76%-5K | 63.96%-3K |
| Net common stock issuance | --9.19M | --54K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -93.00%99K | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 919,000.00%9.19M | 1,425.00%53K | -108.86%-7K | 80.00%-1K | 66.67%-1K | 83.33%-1K | -104.30%-4K | -98.87%79K | -160.02%-5K | 63.96%-3K |
| Net cash flow | ||||||||||
| Beginning cash position | -77.94%1.32M | -28.86%5.04M | -66.73%7.08M | -41.74%6.66M | -6.16%9.99M | -69.41%5.99M | -66.73%7.08M | 66.67%21.28M | -54.61%11.43M | -65.30%10.65M |
| Current changes in cash | -21.45%3.15M | -240.60%-3.72M | 85.61%-2.04M | 62.72%-1.62M | -529.34%-3.34M | 144.84%4M | 35.90%-1.09M | -266.82%-14.2M | -11.66%-4.35M | 114.09%777K |
| End cash Position | -55.31%4.47M | -77.94%1.32M | -28.86%5.04M | -28.86%5.04M | -41.74%6.66M | -6.16%9.99M | -69.41%5.99M | -66.73%7.08M | -66.73%7.08M | -54.61%11.43M |
| Free cash flow | -29.69%-3.11M | -41.15%-5.77M | 22.71%-15.5M | -5.48%-4.58M | 15.04%-4.44M | 53.82%-2.4M | 22.90%-4.09M | -29.48%-20.05M | -8.71%-4.34M | 12.62%-5.22M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data